A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LR / locoregional recurrence

[Related PubMed/MEDLINE]
Total Number of Papers: 55
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LR  (>> Co-occurring Abbreviation)
Long Form:   locoregional recurrence
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods. ACC, AUC, DEGs, DM, OS, PPI, ROC, RS, TIMER, TME
2020 Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. CF, CI, EMR, OS, PET, PFS
2019 Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis. CI, CRT, OR, OS
2019 Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective. DR, ICER, IPD, QALYs, RFS
2019 Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy. HNSCC, LN, PT, TF, TLG-LN
2019 Radiological Staging for Distant Metastases in Breast Cancer Patients with Confirmed Local and/or Locoregional Recurrence: How Useful are Current Guideline Recommendations? DM
2019 Recurrence pattern and outcomes in T4 colon cancer: A single institution analysis. CI, HR
2018 Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer. DM, NSCLC, SBRT
2018 Hypoxic volume evaluated by 18F-fluoromisonidazole positron emission tomography (FMISO-PET) may be a prognostic factor in patients with oral squamous cell carcinoma: preliminary analyses. DFS, FDG, FMISO-PET, HV, MTV, OSCC, TLG
10  2018 Is there a role for salvage re-irradiation in pediatric patients with locoregional recurrent rhabdomyosarcoma? Clinical outcomes from a multi-institutional cohort. RMS
11  2018 Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience. OS, RPS
12  2018 Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell LungCancer. cIII-N2, DFS, LCSD, NSCLC, OS, PORT
13  2018 Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy. cCR, dCRT, DRs, ESCC
14  2018 What is the role of wedge resection for T1a lung cancer? SLR
15  2017 Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery. DM, IMRT, LRF, NSCLC, OS, RT
16  2017 Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer. CI, HR
17  2017 Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. BR/LA, OS, PD, PDAC
18  2017 Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. DM
19  2017 Survival outcomes of consolidation chemoradiotherapy in esophageal cancer patients who achieve clinical complete response but refuse surgery after neoadjuvant chemoradiotherapy. cCR, ESCC, nCRT
20  2017 The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. CSS, DFS, LARC, OS, TME
21  2017 [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection]. CT, DM, ESCC, RT
22  2016 Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer. CTV, NSCLC, OS, PORT
23  2016 Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. CRT, OS, PD, PDAC
24  2016 Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time. BC
25  2016 Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy. DM, ECE, FFDM, FFLR, LNR, NSCLC, OS, PFS, PORT
26  2016 [Patterns of recurrence in patients with stage pT2 N0-1M0 esophageal squamous cell carcinoma after radical resection]. DM, ESCC, POCT
27  2016 [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy]. DM, ESCC, PFS, PORT
28  2015 Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience. CRT, DFS, DMC, LARC, LRC, OS, TME
29  2015 Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival. CI, DR, HR, NSCLC, OS, PORT
30  2015 Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder. LN, RC, STSM, UCB
31  2015 The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. CP, IBTR, RS
32  2014 Managing regional metastasis in patients with cutaneous head and neck melanoma - is selective neck dissection appropriate? CND, ECE, OS, PFS, SND
33  2014 Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer. CRT, RT
34  2013 Oncologic surveillance of breast cancer patients after lipofilling. CI
35  2013 Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy. DM, FFLR, IMD, MLN, NSCLC, OS, PORT
36  2013 Using pretreatment tumor depth and length to select esophageal squamous cell carcinoma patients for nonoperative treatment after neoadjuvant chemoradiotherapy. e-CR, nCRT, OR, SCC
37  2012 ACR Appropriateness Criteria local-regional recurrence (LR) and salvage surgery: breast cancer. LRR
38  2012 Central retroperitoneal recurrences from colorectal cancer: are lymph node and locoregional recurrences the same disease? CRRs, DFS, NR, OS
39  2012 High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients. CRT, DSS, SCC
40  2011 Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. CRM, CRT, DR, DSS, SCC
41  2009 Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy. DR
42  2007 Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. DTC, NR, TBR
43  2006 Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. DM, OS
44  2006 Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTRO. CIF, DM, FU, REACT, SE
45  2005 The impact of a second breast cancer diagnosis on health related quality of life. DR, NP, QOL, WHEL
46  2001 Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. DM, RSTS
47  2001 Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. GI, M-GIST, OS
48  2000 Influence of the surgical treatment on local recurrence of rectal cancer: a prospective study (1980-1992). APE, AR
49  1999 Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. BCT
50  1999 The link between local recurrence and distant metastases in human breast cancer. ---
51  1996 Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). DTC, FTC, LDF, PTC
52  1994 A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma. CR, NPC, PR
53  1992 Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. 5-FU
54  1991 [The prognostic relevance of locoregional recurrence following mastectomy in breast carcinoma]. ---
55  1989 Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. ---